NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-208-2002-0-US-01 Applications of the HMGN1 Pathway US 60/455,728 Abandoned
NCI E-097-2003-0-US-01 TLT-1, a novel inhibitory receptor and uses thereof US 60/455,370 Abandoned
NCI E-115-2003-0-US-01 Programmed Probabilistic Gene Expression Mediated By An Overlapping Bi-Directional Promoter US 60/455,068 Abandoned
NHGRI E-167-2001-2-EP-05 Hepatocyte growth factor (HGF) and/or insulin-like growth factor-1 (IGF-1) for use in myocardial regeneration EP National Stage 03716535.4 Expired
NHGRI E-167-2001-2-PCT-02 Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium PCT PCT PCT/US2003/007731 Expired
NIA E-183-2003-0-US-02 Method For Treating Cognitve Disorders US ORD 10/386,915 Abandoned
NCI E-087-2003-0-US-01 ABCA13 Nucleic Acids and Proteins, and Uses Thereof US 60/454,502 Abandoned
NHGRI E-167-2001-2-CN-07 Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium CN National Stage 3818704.3 Expired
NHGRI E-167-2001-2-IL-03 Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium IL National Stage 165560 Expired
NCI E-321-2000-0-US-02 Antisense Oligonucleotides Targeting Folate Receptor Alpha, And the Use Thereof US ORD 10/093,523 7030236 Abandoned PDF
NINDS E-177-1999-2-US-02 A System and Method for Identifying T Cell Epitopes US National Stage 10/380,147 Abandoned
NCI E-328-2002-0-US-01 Synthesis of Proteins by Cell-Free Protein Expression US 60/454,013 Abandoned
NCI E-049-2003-0-US-01 Apparatus and Process for Dose-Guided Radiotherapy US 60/453,934 Abandoned
NIAID E-232-2004-4-EP-11 Compositions And Methods For Generating An Immune Response EP DIV 10184784.6 Expired
NIAID E-232-2004-4-CA-05 Compositions And Methods For Generating An Immune Response CA National Stage 2478371 Expired
NIAID E-232-2004-4-IN-06 Compositions And Methods For Generating An Immune Response IN National Stage 2623/DELNP/2004 Expired
NIAID E-232-2004-4-AU-04 Compositions And Methods For Generating An Immune Response AU National Stage 2003220111 Expired
NIAID E-232-2004-4-PCT-02 Compositions And Methods For Generating An Immune Response PCT PCT PCT/US2003/007177 Expired
NCI E-131-2000-0-US-06 Methods For Reducing Tumor Growth and Metastasis by Inhibiting MCP-1 Activity US National Stage 10/276,644 Abandoned
NIAID E-232-2004-4-CN-03 Compositions And Methods For Generating An Immune Response CN National Stage 03810451.2 Expired
NIAID E-232-2004-4-JP-08 Compositions And Methods For Generating An Immune Response JP National Stage 2003-574798 Expired
NIAID E-232-2004-2-JP-06 DNA expression vectors and methods of use JP National Stage 2002-500664 Expired
NIAID E-232-2004-4-EP-07 Compositions And Methods For Generating An Immune Response EP National Stage 03716404.3 Abandoned
NCI E-039-2003-0-US-01 Combinatorial Therapy for Protein Signaling Diseases US 60/453,629 Abandoned
NIDCR E-160-2000-0-US-11 Method for identifying compounds modulating taste transduction US CON 10/383,982 7479373 Expired PDF
NCI E-225-2002-0-US-01 Chromatographic Purification of Single-Chain, Variable-Region Anti-HER2/neu Antibody US 60/452,539 Abandoned
NIEHS E-314-2002-0-US-01 Regulation of RNA stability US 60/451,976 Abandoned
NCI E-302-2000-2-NZ-07 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway: A Selective Therapeutic Strategy Against Melanoma NZ National Stage 524636 Abandoned
NHGRI E-018-1997-0-US-08 AIB1, A NOVEL STEROID RECEPTOR CO-ACTIVATOR US DIV 10/379,616 7232890 Abandoned PDF
NCI E-220-2009-0-CA-03 Polynucleotide Sequences of Viruses Associated with Lymphadenopathy Syndrome and/or Acquired Immune Deficiency Syndrome05 CA DIV 1341482 Expired
NIDCR E-138-1994-0-US-06 CARTILAGE-DERIVED MORPHOGENETIC PROTEINS US CON 10/379,830 7220558 Abandoned PDF
NCI E-289-1999-0-US-07 1,8-Naphthalimide Imidazo[4,5,1-de] acridones with Anti-Tumor Activity US National Stage 10/221,236 6664263 Abandoned PDF
NIDA E-086-2005-0-US-01 Use Of Buprenorphine Adn Naloxone For Treating Alcoholism US 60/319,988 Abandoned
CC E-348-2001-0-US-02 Image Guided Liver Intervetnions Based on Magnetic Tracking of Internal Organ Motion US ORD 10/377,528 Abandoned
NCI E-073-2003-0-US-01 Composition And Method Of Use Of Compounds Which Inhibit Protein Kinase C Through Inactivation Of The C1 Domains In Their Regulatory Region US 60/451,214 Abandoned
NICHD E-113-2002-0-US-01 Method for Preparing 17a-acetoxy-11B-(4-N,N-dimethylamino-phenyl)-19- norpregna-4,9-diene-3, 20-dione Intermediates thereof and Methods for the Preparation of Such Intermediates US 60/451,096 Abandoned
NIAID E-185-2003-0-US-01 Assays For Assembly Of Ebola Virus Nucleocapsids US 60/451,317 Abandoned
NIAID E-093-2003-0-US-01 Recovery of Recombinant Human Metapneumovirus (HPMV) From CDNA and Use of Recombinant HMPV in Immunogenic Compositions and As Vectors to Elicit Immune Responses Against HMPV and Other Human Pathogens US 60/451,119 Abandoned
NCI E-057-2002-2-PCT-01 Conjugates of Ligand, Linker and Cytotoxic Agent and Related Compositions and Methods of Use PCT PCT COMB PCT/US03/06344 Expired
NCI E-060-2002-2-PCT-01 DNA-BINDING POLYAMIDE DRUG CONJUGATES PCT PCT COMB PCT/US03/06006 Expired
NCI E-130-2003-0-US-01 Magnetic Resonance Imaging Guidance for High-Dose Rate Brachytherapy of the Prostate US 60/449,850 Abandoned
NCI E-134-2004-0-US-01 Pharmaceutical Composition For Treatment Of Drug Dependencef US 60/449,868 Abandoned
NCI E-147-2003-0-US-01 Identification of Nucelotide Variants using Comparative Fluorometric Hybridization with Reference and Variant Oligonucleotides US 60/451,053 Abandoned
NIDDK E-096-2002-0-AU-04 Obligate Domain-Swapped Dimer of Cyanovirin With Enhanced Anti-Viral Activity AU National Stage 2003212459 Abandoned
NIMH E-002-2004-0-PCT-02 Trans-Splicing Mediated Photodynamic Therapy PCT PCT PCT/US2003/005615 Expired
NIDDK E-096-2002-0-PCT-02 Obligate Domain-Swapped Dimer of Cyanovirin With Enhanced Anti-Viral Activity PCT PCT PCT/US03/06115 Expired
NIMH E-002-2004-0-US-03 Trans-Splicing Mediated Photodynamic Therapy US ORD 10/374,784 Abandoned
NIDDK E-253-1999-1-US-06 Methods for Treating Glaucoma US DIV 10/374,003 Abandoned
NIDDK E-096-2002-0-EP-03 An Obligate Domain-Swapped Dimer of Cyanovirin With Enhanced Anti-Viral Activity EP National Stage 03709399.4 Abandoned
NCI E-230-2002-1-US-01 Catalytic Domains Of Beta(1,4)-Galactosyltransferase I Having Altered Donor And Acceptor Specificiites, Domains, That Promote In Vitro Protein Folding, And Methods For Their Use US 60/450,250 Abandoned